The relationship between changes in serum myostatin and adiponectin levels in patients with obesity undergoing a weight loss program

Abstract

Background An effective strategy for weight loss in patients who are overweight or obese is to reduce body fat mass while maintaining skeletal muscle mass. Adiponectin and myostatin are affected through changes in body composition due to weight loss, and examining their dynamics may contribute to strategies for maintaining skeletal muscle mass through weight loss. We aimed to examine the relationships among myostatin, adiponectin, and body composition, depending on the extent of weight loss, in patients with obesity undergoing a weight loss program. Methods We examined 66 patients with obesity (age: 46.8 ± 14.0 years, body mass index: 34.3 [31.0–38.4] kg/m2) attending a hospital weight loss program. We categorized the patients into two groups, namely an L group (those with a weight reduction of < 5% from baseline) and an M group (those with a weight reduction of > 5% from baseline). All patients underwent blood tests and were assessed for body composition, insulin resistance, adipocytokine and myokine levels, exercise tolerance, and muscle strength at baseline and post-intervention. Results Serum myostatin and adiponectin levels increased post-intervention in both groups. Body weight and %fat decreased, and the rate of lean body mass (%LBM) increased in both groups. Exercise capacity and muscle strength improved in the M group only. Change in (⊿) myostatin correlated with ⊿%fat, ⊿%LBM, and ⊿adiponectin. ⊿adiponectin (β = − 0.262, p = 0.035) was an independent predictor of ⊿myostatin. Conclusions Myostatin and adiponectin might cross-talk and regulate changes in skeletal muscle and fat mass with or without successful weight loss. These findings indicate that evaluating serum myostatin and adiponectin levels in clinical practice could be used to predict the effects of weight loss and help prevent skeletal muscle mass loss.

Reduced Visceral Fat Weight and Body Weight Due to Ingestion of Fermented Collagen Peptide in High-Fat Diet-Fed Obese Mice

“…Adiponectin is a protein secreted by adipocytes; blood adiponectin concentration correlates inversely with visceral fat weight. Although changes in leptin and adiponectin levels were observed in this study, they could be secondary effects caused by changes in body weight (27). Analysis of other blood components such as aspartate aminotransferase and alanine aminotransferase is a topic for future research.…”

Preliminary Report on the Influence of Acute Inflammation on Adiponectin Levels in Older Inpatients with Different Nutritional Status

“…It has been shown that reducing fat tissue while maintaining muscle mass in the weight-loss process in this group of patients leads to an increase in adiponectin concentration. This means that the assessment of serum adiponectin levels can serve as a predictor of the effects of weight loss in patients struggling with obesity [39]. The relationship between adiponectin concentration in the older population and their general condition, muscle mass, and the risk of mortality in this group of patients was investigated by Walowski et al The results suggest that high levels of adiponectin are associated with lower muscle mass, reduced bone mineral content, and lower levels of fatty liver disease.…”

Impact of weekly resistance training set volume on adiponectin, TNF-ALFA and leptin levels in obese individuals: a systematic review

“…However, exercise and diet seem to positively influence adiponectin levels. The study of Takao (2021), for example, analyzed adiponectin levels in obese people before and after a physical exercise program and dietary guidance. The results showed a mean reduction of 7.5% in body composition and an increase in plasma adiponectin concentrations after the end of the program.…”